Literature DB >> 19003782

In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolates.

Michael T Sweeney1, Gordon W Brumbaugh, Jeffrey L Watts.   

Abstract

The purpose of this study was to determine the activities of two antibacterial agents used in the treatment of bovine respiratory infections-tulathromycin, a macrolide, and ceftiofur, a third-generation cephalosporin-alone, in combination with each other, and in combination with each of seven additional antibiotics (tilmicosin, florfenicol, enrofloxacin, danofloxacin, ampicillin, tetracycline, and penicillin G) against bovine Pasteurella multocida (n = 60) and Mannheimia haemolytica (n = 10) isolates for determination of synergy, antagonism, or indifference. Of 458 organism-drug combinations, 160 combinations of tulathromycin and 209 combinations of ceftiofur with eight antimicrobial drugs were indifferent. One combination was antagonistic (ceftiofur + florfenicol against one isolate of P. multocida). Time-kill studies showed loss of cidality for ceftiofur when combined with florfenicol at 1x the minimal inhibitory concentration. Overall, the in vitro data demonstrated that tulathromycin and ceftiofur, in combination with each other or seven other antimicrobial agents, primarily produce an indifferent response with no occurrences of synergism and rare occurrences of antagonism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003782

Source DB:  PubMed          Journal:  Vet Ther        ISSN: 1528-3593


  3 in total

1.  Association between antimicrobial drug class selection for treatment and retreatment of bovine respiratory disease and health, performance, and carcass quality outcomes in feedlot cattle.

Authors:  Johann F Coetzee; Natalia Cernicchiaro; Pritam K Sidhu; Michael D Kleinhenz
Journal:  J Anim Sci       Date:  2020-04-01       Impact factor: 3.159

2.  In vitro and in vivo Synergistic Effects of Florfenicol and Thiamphenicol in Combination Against Swine Actinobacillus pleuropneumoniae and Pasteurella multocida.

Authors:  Porjai Rattanapanadda; Hung-Chih Kuo; Thomas W Vickroy; Chi-Hsuan Sung; Tirawat Rairat; Tsai-Lu Lin; Sze-Yu Yeh; Chi-Chung Chou
Journal:  Front Microbiol       Date:  2019-10-30       Impact factor: 5.640

3.  Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium.

Authors:  Jeanette M Wentzel; Louise J Biggs; Moritz Van Vuuren
Journal:  Onderstepoort J Vet Res       Date:  2022-01-10       Impact factor: 1.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.